Krystal Biotech (KRYS) PT Lowered to $182 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Alec Stranahan lowered the price target on Krystal Biotech (NASDAQ: KRYS) to $182.00 (from $192.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
